Imugene Limited

Imugene Limitedverified

IUGNF

Price:

$0.2

Market Cap:

$92.36M

Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company's HER-Vaxx is in Phase 1b/2 study for gastric cancer. It also engages in developing PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling; and CF33, a combination of genomic sequences from various vaccinia virus strains to generate potent virus. The company has a research ...[Read more]

Industry

Biotechnology

IPO Date

2019-07-05

Stock Exchange

OTC

Ticker

IUGNF

The Enterprise Value as of December 2025 (TTM) for Imugene Limited (IUGNF) is 81.08M

According to Imugene Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 81.08M. This represents a change of -74.52% compared to the average of 318.16M of the last 4 quarters.

Imugene Limited (IUGNF) Historical Enterprise Value (quarterly & annually)

How has IUGNF Enterprise Value performed in the past?

The mean historical Enterprise Value of Imugene Limited over the last ten years is 357.57M. The current 81.08M Enterprise Value has changed 2.17% with respect to the historical average. Over the past ten years (40 quarters), IUGNF's Enterprise Value was at its highest in in the December 2021 quarter at 2.06B. The Enterprise Value was at its lowest in in the December 2005 quarter at 0.

Quarterly (TTM)
Annual

Average

357.57M

Median

90.59M

Minimum

8.99M

Maximum

1.63B

Imugene Limited (IUGNF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Imugene Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.60%

Maximum Annual Enterprise Value = 1.63B

Minimum Annual Increase = -71.38%

Minimum Annual Enterprise Value = 8.99M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202585.38M-71.38%
2024298.32M-28.59%
2023417.75M-54.37%
2022915.48M-43.71%
20211.63B1.60%
202095.80M175.27%
201934.80M-49.32%
201868.68M184.36%
201724.15M168.77%
20168.99M-18.18%

Imugene Limited (IUGNF) Average Enterprise Value

How has IUGNF Enterprise Value performed in the past?

The current Enterprise Value of Imugene Limited (IUGNF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

267.15M

5-year avg

668.66M

10-year avg

357.57M

Imugene Limited (IUGNF) Enterprise Value vs. Peers

How is IUGNF’s Enterprise Value compared to its peers?

Imugene Limited’s Enterprise Value is greater than Alterity Therapeutics Limited (48.31M), less than Starpharma Holdings Limited (152.19M), greater than Satellos Bioscience Inc. (41.10M), greater than Nicox S.A. (31.80M), greater than BioStem Technologies, Inc. (42.41M), greater than Poolbeg Pharma PLC (15.21M), less than VitaSpring Biomedical Co. Ltd. (207.39M), greater than H-Source Holdings Ltd. (2.06M), less than Kintor Pharmaceutical Limited (824.09M), less than Calliditas Therapeutics AB (publ) (11.24B),

Build a custom stock screener for Imugene Limited (IUGNF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Imugene Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Imugene Limited (IUGNF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Imugene Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Imugene Limited's Enterprise Value?

What is the highest Enterprise Value for Imugene Limited (IUGNF)?

What is the 3-year average Enterprise Value for Imugene Limited (IUGNF)?

What is the 5-year average Enterprise Value for Imugene Limited (IUGNF)?

How does the current Enterprise Value for Imugene Limited (IUGNF) compare to its historical average?